Semaglutyd przenika do mleka kobiecego, dlatego obecnie uwaa si, e nie powinien by stosowany w okresie laktacji
Patients can expect some discomfort and swelling in the days and weeks following the procedure, and should plan to take some time off work to allow for proper healing
Patients on GLP-1 therapy, especially postmenopausal women, are at increased risk if weight loss is not supported by regular exercise and adequate protein intake
The excellent antioxidant activity of QT assists in protecting the human body from oxidative stress harm by preventing and reducing lipid, protein, and DNA oxidation in vivo 77
Since we practice evidence-based medicine that follows the available current research, we have looked at what research is available for this compound that explains its mechanism of action and/or evaluates its efficacy in the treatment of soft tissue injuries
The 2024 Endocrine Society guideline explicitly recommends long-term or indefinite pharmacotherapy for patients with BMI of 30 or above who have achieved clinically meaningful weight loss on GLP-1 agonists [6]